NCT06251310View on ClinicalTrials.gov

SW-682 in Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

January 31, 2030

Study Completion Date

June 30, 2030

Conditions
Advanced Solid TumorMesothelioma, Malignant
Interventions
DRUG

SW-682

SW-682 tablet administered orally

DRUG

Combination Therapy

Appropriate combination therapy

Trial Locations (9)

37203

ACTIVE_NOT_RECRUITING

SpringWorks Clinical Trial Site, Nashville

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

85258

RECRUITING

SpringWorks Clinical Trial Site, Scottsdale

90033

RECRUITING

USC/Norris Comprehensive Cancer Center, Los Angeles

90095

RECRUITING

SpringWorks Clinical Trial Site, Los Angeles

92093

RECRUITING

UC San Diego Moores Cancer Center, La Jolla

97239

RECRUITING

Knight Cancer Institute Clinical Trials, Portland

All Listed Sponsors
lead

SpringWorks Therapeutics, Inc.

INDUSTRY